Showing results (2001-2010 of 2,148) with videos related to

Sort By:
Pageof 215
Cancer Discovery|July 2, 2020
Leukemia Cell of Origin Influences Apoptotic Priming and Sensitivity to LSD1 InhibitionSheng F Cai, S Haihua Chu, Aaron D Goldberg, et al.
The American Surgeon|June 2, 2022
Grade 1 Internal Carotid Artery Blunt Cerebrovascular Injury Persistence Risks Stroke With Current Management: An EAST Multicenter StudySarah Yang, Emily Esposito, Chance Spalding, et al.
Current Biology : CB|April 25, 2017
Direct Brain Stimulation Modulates Encoding States and Memory Performance in HumansYoussef Ezzyat, James E Kragel, John F Burke, et al.
Transplantation and Cellular Therapy|April 13, 2026
The Impact of Post-Transplant Interventions and Chronic GVHD on Survival in Myeloid Malignancies Harboring TP53 AlterationsMoataz Ellithi, Sandeep Raj, Maria Bromberg, et al.
Blood Advances|July 17, 2023
Samples from patients with AML show high concordance in detection of mutations by NGS at local institutions vs central laboratoriesUma Borate, Fei Yang, Richard Press, et al.
Annals of Surgery|October 16, 2020
Evidence-Based and Clinically Relevant Outcomes for Hemorrhage Control Trauma TrialsJohn B Holcomb, Ernest E Moore, Jason L Sperry, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 16, 2025
A Phase I Study of FHD-286, a Dual BRG1/BRM (SMARCA4/SMARCA2) Inhibitor, in Patients with Advanced Myeloid MalignanciesCourtney D DiNardo, Amir T Fathi, Ashwin Kishtagari, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2020
Mutant Isocitrate Dehydrogenase 1 Inhibitor Ivosidenib in Combination With Azacitidine for Newly Diagnosed Acute Myeloid LeukemiaCourtney D DiNardo, Anthony S Stein, Eytan M Stein, et al.
Nature Communications|March 5, 2025
Virtual library docking for cannabinoid-1 receptor agonists with reduced side effectsTia A Tummino, Christos Iliopoulos-Tsoutsouvas, Joao M Braz, et al.
Biorxiv : the Preprint Server for Biology|February 8, 2024
Large library docking for cannabinoid-1 receptor agonists with reduced side effectsTia A Tummino, Christos Iliopoulos-Tsoutsouvas, Joao M Braz, et al.
Pageof 215